District Court Dismisses Mylan's Authorized Generics Case Against FDA

Drug Industry Daily
KEYWORDS courts / generic
A A

The FDA recently won another victory in the legal battle over authorized generics when a federal judge dismissed Mylan Pharmaceuticals’ lawsuit challenging the agency’s position on the controversial practice.

To View This Article:

Login

Subscribe To Drug Industry Daily